Brachytherapy + EBRT for high-risk PCa offers ‘excellent’ outcomes

Permanent brachytherapy and supplemental external beam radiation therapy for high-risk prostate cancer offers “excellent” long-term biochemical control and cancer-specific survival, according to researchers.
Renal and Urology News